The Sleeping Beauty (ballet) it with most of the final act, as well as other sections. The selections in this version are listed as follows: The Walt Disney Company has registered a trademark with the US Patent and Trademark Office, filed 13 March 2007, for the name "Princess Aurora" that covers production and distribution of motion picture films; production of television programs; production of sound and video recordings. Some suggest that this may limit the ability to perform this ballet, from which Disney acquired some of the music for its animated 1959 film "Sleeping Beauty". The Sleeping Beauty (ballet) The Sleeping Beauty ( /
Sleeping Beauty transposon system widespread human application of gene therapy in first-world nations as well as countries with developing economies can be envisioned if the costs of the vector system are affordable. Because the SB system is composed solely of DNA, the costs of production and delivery are considerably reduced compared to viral vectors. The first clinical trials using SB transposons in genetically modified T cells will test the efficacy of this form of gene therapy in patients at risk of death from advanced malignancies. Sleeping Beauty transposon system The "Sleeping Beauty" transposon system is a synthetic DNA transposon designed to introduce precisely defined